Nathalie Renard

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

D Liénard, Patricia Ewalenko, Jean-Baptiste Delmotte et al. · Journal of Clinical Oncology · 1992 · 723 citations

Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)

Nathalie Renard, D. Liénard, Laurence Lespagnard et al. · International Journal of Cancer · 1994 · 143 citations

Probiotics enhance the clearance of human papillomavirus-related cervical lesions

Véronique Verhoeven, Nathalie Renard, Amin Makar et al. · European Journal of Cancer Prevention · 2012 · 127 citations

Cervical Cytology, Precancerous Lesions, Gynecology +16

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.

Krzysztof Warzocha, Gilles Salles, Jacques Bienvenu et al. · Journal of Clinical Oncology · 1997 · 112 citations

Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group

T. J. de Vries, Miriam Smeets, Ruurd de Graaf et al. · The Journal of Pathology · 2001 · 108 citations